SCS |
single-cell sequencing |
ITH |
intratumor heterogeneity |
TME |
tumor microenvironment |
HGP |
Human Genome Project |
NGS |
next-generation sequencing |
TGS |
third-generation sequencing |
ScRNA-Seq |
single-cell RNA sequencing |
WGS |
whole-genome sequencing |
WTS |
whole-transcriptome sequencing |
ATAC-Seq |
assay for transposase-accessible chromatin with sequencing |
SnRNA-Seq |
single-nucleus RNA sequencing |
ScChIP-Seq |
single-cell chromatin immunocleavage sequencing |
TSCS |
topographic single-cell sequencing |
CROP-Seq |
CRISPR droplet sequencing |
LCM |
laser-capture microdissection |
FACS |
fluorescence-activated cell sorting |
IMS |
immunomagnetic separation |
ROT |
Raman optical tweezers |
TAS |
micro-total analysis system |
WGA |
whole-genome amplification |
WTA |
whole-transcriptome amplification |
PCR |
polymerase chain reaction |
DOP-PCR |
degenerative-oligonucleotide-primed PCR |
MDA |
multiple displacement amplification |
MLBAC |
multiple annealing- and looping-based amplification cycle |
IVT |
in vitro transcription |
GGN-ADC |
ground-glass nodule adenocarcinoma |
TLR |
Toll-like receptor |
VEGF |
vascular endothelial growth factor |
SADC |
solid adenocarcinoma |
HIF-1 |
hypoxia-inducible factor-1 |
TIMs |
tumor-infiltrating myeloid cells |
TAMs |
tumor-associated macrophages |
NSCLC |
non-small-cell lung cancer |
TILs |
tumor-infiltrating lymphocytes |
CTCs |
circulating tumor cells |
CNV |
copy number variation |
PDX |
patient-derived xenograft |
HCC |
hepatocellular carcinoma |
Tregs |
regulatory T cells |
NASH |
non-alcoholic steatohepatitis |
TSS |
transcription start site |
HBV |
hepatitis B virus |
DDX5 |
DEAD-box protein 5 |
HSCs |
hepatocarcinoma stem cells |
EMT |
epithelial–mesenchymal transition |
GPCR |
G protein-coupled receptor |
FGFR |
fibroblast growth factor receptor |
CAFs |
cancer-associated fibroblasts |
GC |
gastric cancer |
HDGC |
hereditary diffuse gastric cancer |
BRD4 |
bromodomain-containing protein 4 |
IPMNs |
intraductal papillary myxomas |
PD-L1 |
programmed death ligand 1 |
ER |
estrogen receptor |
PR |
progesterone receptor |
TFs |
transcription factors |
HER2 |
human epidermal growth factor receptor 2 |
DCIS |
ductal carcinoma in situ
|
TNBC |
triple-negative breast cancer |
NAC |
neoadjuvant chemotherapy |
FABP4 |
fatty acid-binding protein 4 |
TRM |
tissue-resident memory |
T-ALL |
T-cell acute lymphoblastic leukemia |
DLBCL |
diffuse large B-cell lymphoma |
NHL |
non-Hodgkin’s lymphoma |
VRL |
vitreoretinal lymphoma |
MCL |
mantle cell lymphoma |
CTCL |
cutaneous T-cell lymphoma |
LCH |
Langerhans cell histiocytosis |
HCA |
Human Cell Atlas |